Yanagisawa S, Oikawa Y, Mai Endo, Yoshimasa Kamei, Yoshihisa Sugimura, Shimada A. Magnesium sulfate may unmask subclinical excess vasopressinase-induced arginine vasopressin disorder. J Clin Endocrinol Metab. 2026 (In press).
Sasako T, Ueki K, Miyoshi K, Miyake K, Aoyama T, Okazaki Y, Ishizuka N, Yamauchi T, Noda M, Kadowaki T; J-DOIT3 Study Group. Effect of a Multifactorial Intervention on Retinopathy in People With Type 2 Diabetes: A Secondary Analysis of the J-DOIT3 Randomized Clinical Trial. JAMA Ophthalmol. 2025 Oct 23:e253819.
Takenaka Y*, Inoue I*, Ikeda M, Kakinuma Y. A Fluorescence-Based Histidine-Imidazole Polyacrylamide Gel Electrophoresis (HI-PAGE) Method for Rapid and Practical Lipoprotein Profiling and LDL-C Quantification in Clinical Samples. Biomedicines. 2025; 13(10):2560. (* equally contributed to this work.)
Fukui T, Kobayashi T, Awata T, Ikegami H, Imagawa A, Oikawa Y, Osawa H, Kawasaki E, Kuwabara M, Kobayashi K, Katsuki T, Kanatsuna N, Kozawa J, Kodani N, Shimada A, Shimoda M, Takahashi K, Chujo D, Tsujimoto T, Tsuchiya K, Terasaki J, Nagasawa K, Noso S, Horie I, Yasuda K, Yasuda H, Hanafusa T, Kajio H; Japanese Type 1 Diabetes Database Study (TIDE-J). Slowly progressive type 1 diabetes and female sex as associated factors for pancreatic abnormalities on diagnostic imaging indicating precancerous potential. BMJ Open Diabetes Res Care. 2025 Sep 15;13(5):e005229.
Horii T, Kawaguchi M, Ikegami Y, Oikawa Y, Shimada A, Mihara K. Risk of severe lower extremity arterial disease in elderly Japanese patients with type 2 diabetes: a propensity score-matched model analysis of sodium-glucose cotransporter 2 inhibitors versus metformin. BMJ Open Diabetes Res Care. 2025 Jul 17;13(4):e005103.
Noso S, Chujo D, Imagawa A, Kawasaki E, Awata T, Yasuda K, Abiru N, Kodani N, Oikawa Y, Fukui T, Katsuki T, Kozawa J, Nagasawa K, Osawa H, Takahashi K, Tsuchiya K, Shimoda M, Yasuda H, Maeda N, Shimada A, Kobayashi T, Hanafusa T, Kajio H, Ikegami H; Japanese Type 1 Diabetes Database Study (TIDE-J) Genetics. Rapid and Slow Progressors Toward β-Cell Depletion and Their Predictors in Type 1 Diabetes: Prospective Longitudinal Study in Japanese Type 1 Diabetes (TIDE-J). Diabetes Care. 2025 Aug 1;48(8):1438-1445.
Inoue I, Maruyama Y. A case of Brugada Phenocopy with Familial Hypercholesterolemia. Journal of Ningen Dock and Preventive Medical Care. 2025 (In press).
Horii T, Kawaguchi M, Ikegami Y, Oikawa Y, Shimada A, Mihara K. Factors associated with severe lower extremity artery disease in type 2 diabetes based on a large scale claims database in Japan. Sci Rep. 2025 Jun 3;15(1):19358.
Nakanishi S*, Sato H*, Oikawa Y, Ikebukuro K, Shimada A. Shared Pathogenic Features Between Serotonin Receptor Antagonist-Associated Diabetic Ketosis and Ketosis-Prone Type 2 Diabetes: A Case Report. Cureus. 2025 Apr 23;17(4):e82833. (* equally contributed to this work.)
Oikawa Y, Haisa A, Satomura A, Shimada A. Update on slowly progressive type 1 diabetes. J Diabetes Investig. 2025 Jun;16(6):989-991.
Mitsui E*, Satomura A*, Oikawa Y, Haisa A, Shimada A. Mitochondrial DNA 3243 mutation may be associated with positivity of zinc transporter 8 autoantibody in cases of slowly progressive type 1 diabetes mellitus. Diabetol Int. 2024 Nov 21;16(1):188-193. (* equally contributed to this work.)
Ebisuno T, Tachibana M, Imagawa A, Kanatsuna N, Terasaki J, Abiru N, Awata T, Ikegami H, Oikawa Y, Osawa H, Katsuki T, Kawasaki E, Kozawa J, Kobayashi T, Shimada A, Takahashi K, Chujo D, Tsuchiya K, Nagasawa K, Fukui T, Yasuda K, Yasuda H, Kajio H, Hanafusa T. Analysis of thyroid autoantibodies and the risk of insulin depletion after the clinical onset of acute-onset type 1 diabetes in Japanese patients: the TIDE-J study. Diabetol Int. 2024 Oct 9;16(1):39-49.
Horii T, Masudo C, Takayanagi Y, Oikawa Y, Shimada A, Mihara K. Adherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12 month follow-up: Japanese real-world data. J Diabetes Investig. 2024 Nov;15(11):1578-1584.
Horii T, Oikawa Y, Kidowaki K, Shimada A, Mihara K. Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of Japan. J Diabetes Investig. 2024 Nov;15(11):1651-1662.
Ito D, Inoue I, Yanagisawa S, Inoue K, Saito D, Sumita T, Uchida Y, Inukai K, Shimada A. Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5-year observational follow-up of a randomized, 24-week, active-controlled trial: Effect of ipragliflozin in MASLD. J Diabetes Investig. 2024 Sep;15(9):1220-1230.
Meguro S, Sakane N, Hosoda K, Hirota Y, Itoh A, Kato K, Kodani N, Kuroda A, Matsuhisa M, Miura J, Shimada A, Tone A, Toyoda M, Murata T & The ISCHIA Study Group. Diurnal variation in the association between the scan frequency of isCGM and CGM metrics: post hoc analysis of the ISCHIA study. Diabetol Int. 2024 Aug 19;15(4):828-836.
Haisa A, Oikawa Y, Satomura A, Suzuki S, Nakanishi S, Fujisawa M, Morita H, Katsuki T, Shimada A. High glutamic acid decarboxylase antibody titers may be associated with a decline in β-cell function over time and future insulin deficiency in latent autoimmune diabetes in adults. Diabetes Res Clin Pract. 2024 Jul 30;215:111799.
Matsuo K, Inoue I, Matsuda T, Arai T, Nakano S. Relative Increase in Production Ratio of Small Dense Low-Density Lipoprotein in Acute Coronary Syndrome with High Coronary Plaque Burden: An Ex-Vivo Analysis. Heart Vessels. 2025 Jan;40(1):26-35.
Shimada A, Kawasaki E, Abiru N, Awata T, Oikawa Y, Osawa H, Kajio H, Kozawa J, Takahashi K, Chujo D, Noso S, Fukui T, Miura J, Yasuda K, Yasuda H, Imagawa A, Ikegami H. Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM, probable) cases (English Version). Diabetol Int. 2024 Nov 12;16(1):1-6.
Shimada A, Kawasaki E, Abiru N, Awata T, Oikawa Y, Osawa H, Kajio H, Kozawa J, Takahashi K, Chujo D, Noso S, Fukui T, Miura J, Yasuda K, Yasuda H, Imagawa A, Ikegami H. Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM, probable) cases (English Version). J Diabetes Investig. 2025 Jan;16(1):163-168.
Kawasaki E, Awata T, Ikegami H, Imagawa A, Oikawa Y, Osawa H, Katsuki T, Kanatsuna N, Kawamura R, Kozawa J, Kodani N, Kobayashi T, Shimada A, Shimoda M, Takahashi K, Chujo D, Tsujimoto T, Tsuchiya K, Terakawa A, Terasaki J, Nagasawa K, Noso S, Fukui T, Horie I, Yasuda K, Yasuda H, Yanai H, Hanafusa T, Kajio H; Japanese Type 1 Diabetes Database Study (TIDE-J). Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes. J Diabetes Investig. 2024 July 1;15(7):835-842.
Takenaka Y, Kakinuma Y, Ikeda M, Inoue I. Shared Mechanisms in Pparγ1sv and Pparγ2 Expression in 3T3-L1 Cells: Studies on Epigenetic and Positive Feedback Regulation of Pparγ during Adipogenesis. PPAR Res. 2024 Jun 7;2024:5518933.
Yanagisawa S, Oikawa Y, Endo M, Inoue K, Nakajima R, Yasuda S, Sato M, Iwata N, Fujisawa H, Suzuki A, Sugimura Y, Isshiki M, Shimada A. A pregnant woman with excess vasopressinase-induced diabetes insipidus complicated by central diabetes insipidus like lymphocytic infundibulo-neurohypophysitis: a case report. Case Rep Endocrinol. 2024 Apr 13;2024:8687054.
ISCHIA Study Group; Murata T, Hirota Y, Hosoda K, Kato K, Kouyama K, Kouyama R, Kuroda A, Matoba Y, Matsuhisa M, Meguro S, Miura J, Nishimura K, Sakane N, Shimada A, Suzuki S, Tone A, Toyoda M. Predictors of the effectiveness of isCGM usage in adults with type 1 diabetes mellitus: post-hoc analysis of the ISCHIA study. Diabetol Int. 2024 Feb 15;15(3):400-405.
Mizutani G, Isshiki M, Shimizu E, Saito D, Shimada A. Pheochromocytoma With High Adrenocorticotropic Hormone Production Capacity Without Pigmentation and Cushingoid Symptoms: A Case Report With a Literature Review. Cureus. 2024 Feb 1;16(2):e53358.
Shimada A, Kawasaki E, Abiru N, Awata T, Oikawa Y, Osawa H, Kajio H, Kozawa J, Takahashi K, Chujo D, Noso S, Fukui T, Miura J, Yasuda K, Yasuda H, Imagawa A, Ikegami H. New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version). J Diabetes Investig. 2024 Feb;15(2):254-257.
Shimada A, Kawasaki E, Abiru N, Awata T, Oikawa Y, Osawa H, Kajio H, Kozawa J, Takahashi K, Chujo D, Noso S, Fukui T, Miura J, Yasuda K, Yasuda H, Imagawa A, Ikegami H. New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version). Diabetol Int. 2024 Jan 8;15(1):1-4.
Yamanouchi Y, Senbonmatsu T, Yamaguchi T, Inoue I, Goto S, Soma T, Maruyama Y, Adachi M, Shinozuka N, Muramatsu T. Medical Record Survey after Comprehensive Health Checkup Referral and Its Contribution to the Early Detection of Cancer. J Pers Med. 2024, 14:59.
Kawai S, Yamakage H, Kotani K, Noda M, Satoh-Asahara N, Hashimoto K. Differences in metabolic characteristics between Metabolically Healthy Obesity (MHO) and Metabolically Unhealthy Obesity (MUO) in weight reduction therapy. Endocr J. 2023 Dec 28;70(12):1175-1186.
Nishimura R, Shimada A, Abiru N, Matsuhisa M, Takahashi Y, Ikegami H. Association between glycemic control and patient-reported outcomes in adults with type 1 diabetes in Japan: the SAGE study subanalysis. Diabetol Int. 2023 Nov 22;15(2):212-222.
Toyoda M, Murata T, Hirota Y, Hosoda K, Kato K, Kouyama K, Kouyama R, Kuroda A, Matoba Y, Matsuhisa M, Meguro S, Miura J, Nishimura K, Shimada A, Suzuki S, Tone A, Sakane N; ISCHIA Study Group. Possible Relationship between the Deteriorated Accuracy of Intermittent-Scanning Continuous Glucose Monitoring Device and the Contact Dermatitis: Post-hoc analysis of the ISCHIA Study. Tokai J Exp Clin Med. 2023 Sep 20;48(3):83-90.